Prior radiotherapy was allowed if not involving more than 30% of the bone marrow or was given within the 4 weeks prior to study entry.
In a series of 22 patients, high dose BCNU (800-1,000mg m-2) with autologous bone marrow transplantation was given as the first post-surgical treatment for grade IV astrocytoma and followed by full dose radiotherapy.
When extensively T-cell-depleted marrow or mobilized blood was given, a low percentage (17%) of mixed chimerism could be detected at the stromal cell level, suggesting a limited but effective capacity of reconstituting the BM microenvironment [ 4].
In a prior case, another patient was given bone marrow stem cell transplant from a baboon, a species naturally resistant to HIV, but that patient passed away from complications of AIDS after transient improvement of symptoms.
After informed consent was given, bone marrow (BM) and peripheral blood (PB) specimens (72 BM and 32 PB) were obtained at the time of diagnosis during routine clinical assessment of 104 patients with AML, who presented at the University Hospital Aachen, Germany, between 1995 and 2008.
All donors were healthy donors in a bone marrow graft program and informed consent was given.
This increased tumor incidence was not seen when the carcinogen was given after bone marrow transplantation to overcome the mast cell deficiency [ 25].
After 8 days, 6 Gy whole-body irradiation was given; followed within 24 h by homologous bone marrow transplantation.
In 1962, she was given steroids which activated a dormant case of bone marrow tuberculosis.
Reinduction chemotherapy was given as soon as relapse was diagnosed in the marrow.
